Evidence map›Paper›PMID 35908686›Full record

ArticleJournal of molecular and cellular cardiology2022

Improved Ca

Ewan D Fowler, Nan Wang, Melanie J Hezzell, Guillaume Chanoit, Jules C Hancox, Mark B Cannell

Open access · hybridAbstract readClinical Trial, Phase I
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of molecular and cellular cardiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. CaJournal of molecular and cellular cardiology · 2023
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ewan D FowlerSchool of Physiology, Pharmacology & Neuroscience, Faculty of Biomedical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK.
Nan WangSchool of Physiology, Pharmacology & Neuroscience, Faculty of Biomedical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK.
Melanie J HezzellUniversity of Bristol Veterinary School, Langford, Bristol BS40 5DU, UK.
Guillaume ChanoitUniversity of Bristol Veterinary School, Langford, Bristol BS40 5DU, UK.
Jules C HancoxSchool of Physiology, Pharmacology & Neuroscience, Faculty of Biomedical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK.
Mark B CannellSchool of Physiology, Pharmacology & Neuroscience, Faculty of Biomedical Sciences, University of Bristol, University Walk, Bristol BS8 1TD, UK. Electronic address: mark.cannell@bristol.ac.uk.
University of Bristol · GB

Funding

British Heart Foundation FS/IBSRF/21/25071British Heart Foundation PG/15/106/31915Medical Research Council MR/N002903/1
6 · The paper itself

Abstract

Loss of ventricular action potential (AP) early phase 1 repolarization may contribute to the impaired Ca

Indexed as

Heart FailureMyocytes, CardiacAction PotentialsAnimalsCalciumGuinea PigsHeart VentriclesHumansRabbitsSodiumCalciumSodiumArrhythmiasCalcium cycling/excitation-contraction couplingElectrophysiologyHeart failureSudden cardiac death

Identifiers

PMID35908686
PMCPMC11773631
OpenAlexW4288457436

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.